

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of mast cell degranulation (GO:0043304) | 9.99720904 |
| 2 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 9.99697003 |
| 3 | positive regulation of regulated secretory pathway (GO:1903307) | 9.76036776 |
| 4 | * angiotensin maturation (GO:0002003) | 9.74871681 |
| 5 | leukotriene biosynthetic process (GO:0019370) | 9.63288706 |
| 6 | positive regulation of megakaryocyte differentiation (GO:0045654) | 9.62319827 |
| 7 | regulation of mast cell activation involved in immune response (GO:0033006) | 9.45204655 |
| 8 | production of molecular mediator involved in inflammatory response (GO:0002532) | 8.68221603 |
| 9 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 8.24818603 |
| 10 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 7.61949235 |
| 11 | regulation of leukocyte degranulation (GO:0043300) | 7.31609494 |
| 12 | regulation of mast cell activation (GO:0033003) | 7.23034298 |
| 13 | regulation of regulated secretory pathway (GO:1903305) | 6.15724667 |
| 14 | leukotriene metabolic process (GO:0006691) | 6.06195162 |
| 15 | low-density lipoprotein particle clearance (GO:0034383) | 6.01038519 |
| 16 | serotonin metabolic process (GO:0042428) | 6.00358427 |
| 17 | tyrosine phosphorylation of STAT protein (GO:0007260) | 5.71450178 |
| 18 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 5.69890097 |
| 19 | keratinization (GO:0031424) | 5.51796004 |
| 20 | fatty acid elongation (GO:0030497) | 5.50388351 |
| 21 | positive regulation of chemokine secretion (GO:0090197) | 5.40495943 |
| 22 | monoamine transport (GO:0015844) | 5.39148752 |
| 23 | positive regulation of acute inflammatory response (GO:0002675) | 5.30945484 |
| 24 | primary amino compound metabolic process (GO:1901160) | 5.03690409 |
| 25 | thrombin receptor signaling pathway (GO:0070493) | 4.98719452 |
| 26 | triglyceride catabolic process (GO:0019433) | 4.73743247 |
| 27 | NADH metabolic process (GO:0006734) | 4.61107755 |
| 28 | positive regulation of B cell mediated immunity (GO:0002714) | 4.58295306 |
| 29 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 4.58295306 |
| 30 | regulation of sequestering of triglyceride (GO:0010889) | 4.50858473 |
| 31 | positive regulation of calcium-mediated signaling (GO:0050850) | 4.43624102 |
| 32 | mast cell degranulation (GO:0043303) | 4.33274163 |
| 33 | mast cell activation involved in immune response (GO:0002279) | 4.33274163 |
| 34 | fatty acid derivative biosynthetic process (GO:1901570) | 4.23546318 |
| 35 | icosanoid biosynthetic process (GO:0046456) | 4.23546318 |
| 36 | regulation of megakaryocyte differentiation (GO:0045652) | 4.22483891 |
| 37 | neutral lipid catabolic process (GO:0046461) | 4.22229918 |
| 38 | acylglycerol catabolic process (GO:0046464) | 4.22229918 |
| 39 | keratinocyte differentiation (GO:0030216) | 4.19366109 |
| 40 | transcytosis (GO:0045056) | 4.10973131 |
| 41 | complement activation, classical pathway (GO:0006958) | 4.09729281 |
| 42 | regulation of chemokine secretion (GO:0090196) | 4.07649144 |
| 43 | complement activation (GO:0006956) | 4.00525481 |
| 44 | diacylglycerol metabolic process (GO:0046339) | 3.98064500 |
| 45 | response to phenylpropanoid (GO:0080184) | 3.95675764 |
| 46 | positive regulation of exocytosis (GO:0045921) | 3.94512194 |
| 47 | triglyceride biosynthetic process (GO:0019432) | 3.89489100 |
| 48 | bone remodeling (GO:0046849) | 3.88636907 |
| 49 | peptide cross-linking (GO:0018149) | 3.88084416 |
| 50 | mammary gland alveolus development (GO:0060749) | 3.82107835 |
| 51 | lipid storage (GO:0019915) | 3.78734955 |
| 52 | indolalkylamine metabolic process (GO:0006586) | 3.78111170 |
| 53 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 3.76047754 |
| 54 | cytokine production involved in immune response (GO:0002367) | 3.75077555 |
| 55 | lipoxygenase pathway (GO:0019372) | 3.69924490 |
| 56 | acylglycerol biosynthetic process (GO:0046463) | 3.68806390 |
| 57 | neutral lipid biosynthetic process (GO:0046460) | 3.68806390 |
| 58 | actin nucleation (GO:0045010) | 3.68786564 |
| 59 | glomerular filtration (GO:0003094) | 3.65225679 |
| 60 | polyol transport (GO:0015791) | 3.64890049 |
| 61 | ethanol oxidation (GO:0006069) | 3.64593986 |
| 62 | mast cell activation (GO:0045576) | 3.63978102 |
| 63 | primary alcohol metabolic process (GO:0034308) | 3.60986688 |
| 64 | * peptide hormone processing (GO:0016486) | 3.58497737 |
| 65 | establishment of skin barrier (GO:0061436) | 3.57464652 |
| 66 | linoleic acid metabolic process (GO:0043651) | 3.57113686 |
| 67 | unsaturated fatty acid biosynthetic process (GO:0006636) | 3.53198964 |
| 68 | very long-chain fatty acid metabolic process (GO:0000038) | 3.52768044 |
| 69 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.50982047 |
| 70 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 3.48276317 |
| 71 | retinol metabolic process (GO:0042572) | 3.45236518 |
| 72 | regulation of cholesterol storage (GO:0010885) | 3.38723513 |
| 73 | definitive hemopoiesis (GO:0060216) | 3.38024008 |
| 74 | regulation of B cell mediated immunity (GO:0002712) | 3.36047309 |
| 75 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.33286653 |
| 76 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.32528823 |
| 77 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.29587405 |
| 78 | adult feeding behavior (GO:0008343) | 3.28343169 |
| 79 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.26491225 |
| 80 | epidermal cell differentiation (GO:0009913) | 3.24177962 |
| 81 | protein activation cascade (GO:0072376) | 3.24144918 |
| 82 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.23935532 |
| 83 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.23935532 |
| 84 | activation of JUN kinase activity (GO:0007257) | 3.22979397 |
| 85 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.22122570 |
| 86 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.21908436 |
| 87 | renal filtration (GO:0097205) | 3.18486996 |
| 88 | ethanol metabolic process (GO:0006067) | 3.18129353 |
| 89 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.17634214 |
| 90 | desmosome organization (GO:0002934) | 3.15381903 |
| 91 | triglyceride metabolic process (GO:0006641) | 3.13880011 |
| 92 | positive regulation of lipid storage (GO:0010884) | 3.12485811 |
| 93 | heparin biosynthetic process (GO:0030210) | 3.09490480 |
| 94 | heparin metabolic process (GO:0030202) | 3.09490480 |
| 95 | alpha-linolenic acid metabolic process (GO:0036109) | 3.08992993 |
| 96 | virion attachment to host cell (GO:0019062) | 3.08798290 |
| 97 | adhesion of symbiont to host cell (GO:0044650) | 3.08798290 |
| 98 | phosphatidic acid metabolic process (GO:0046473) | 3.08042757 |
| 99 | phosphatidic acid biosynthetic process (GO:0006654) | 3.08042757 |
| 100 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.08023276 |
| 101 | germ cell migration (GO:0008354) | 3.07006802 |
| 102 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.06461235 |
| 103 | fatty acid homeostasis (GO:0055089) | 3.05671377 |
| 104 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 3.05333663 |
| 105 | regulation of calcium-mediated signaling (GO:0050848) | 3.04488824 |
| 106 | regulation of water loss via skin (GO:0033561) | 3.01148974 |
| 107 | megakaryocyte development (GO:0035855) | 2.99569290 |
| 108 | glycerolipid catabolic process (GO:0046503) | 2.98622079 |
| 109 | regulation of lipoprotein metabolic process (GO:0050746) | 2.96801325 |
| 110 | positive regulation of macrophage differentiation (GO:0045651) | 2.94387753 |
| 111 | molting cycle (GO:0042303) | 2.94061077 |
| 112 | hair cycle (GO:0042633) | 2.94061077 |
| 113 | cellular biogenic amine biosynthetic process (GO:0042401) | 2.92565505 |
| 114 | amine biosynthetic process (GO:0009309) | 2.92565505 |
| 115 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.87326572 |
| 116 | acylglycerol metabolic process (GO:0006639) | 2.87321591 |
| 117 | thioester biosynthetic process (GO:0035384) | 2.85999037 |
| 118 | acyl-CoA biosynthetic process (GO:0071616) | 2.85999037 |
| 119 | neutral lipid metabolic process (GO:0006638) | 2.82989262 |
| 120 | response to nitric oxide (GO:0071731) | 2.82952386 |
| 121 | plasma lipoprotein particle clearance (GO:0034381) | 2.81822742 |
| 122 | lipoprotein transport (GO:0042953) | 2.77190976 |
| 123 | regulation of macrophage differentiation (GO:0045649) | 2.72923990 |
| 124 | adhesion of symbiont to host (GO:0044406) | 2.72626440 |
| 125 | primary alcohol catabolic process (GO:0034310) | 2.72190547 |
| 126 | response to dietary excess (GO:0002021) | 2.70334650 |
| 127 | regulation of acute inflammatory response (GO:0002673) | 2.69473251 |
| 128 | regulation of macrophage chemotaxis (GO:0010758) | 2.69173183 |
| 129 | intestinal absorption (GO:0050892) | 2.69055000 |
| 130 | barbed-end actin filament capping (GO:0051016) | 2.68734620 |
| 131 | positive regulation of pseudopodium assembly (GO:0031274) | 2.68531565 |
| 132 | low-density lipoprotein particle remodeling (GO:0034374) | 2.68362446 |
| 133 | multicellular organismal water homeostasis (GO:0050891) | 2.68160145 |
| 134 | negative regulation of meiosis (GO:0045835) | 2.68069481 |
| 135 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.66235474 |
| 136 | regulation of tyrosine phosphorylation of Stat1 protein (GO:0042510) | 2.65543866 |
| 137 | glycerol metabolic process (GO:0006071) | 2.64444518 |
| 138 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.61044685 |
| 139 | regulation of pseudopodium assembly (GO:0031272) | 2.60844603 |
| 140 | positive regulation of antigen processing and presentation (GO:0002579) | 2.58751377 |
| 141 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.58654020 |
| 142 | positive regulation of cholesterol efflux (GO:0010875) | 2.58046266 |
| 143 | complement activation, alternative pathway (GO:0006957) | 2.57775483 |
| 144 | negative regulation of amino acid transport (GO:0051956) | 2.57661804 |
| 145 | indole-containing compound metabolic process (GO:0042430) | 2.56118157 |
| 146 | renal system process involved in regulation of blood volume (GO:0001977) | 2.55788172 |
| 147 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 2.52724172 |
| 148 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 2.52724172 |
| 149 | cellular response to nitric oxide (GO:0071732) | 2.51180139 |
| 150 | epidermis development (GO:0008544) | 2.50946774 |
| 151 | production of molecular mediator of immune response (GO:0002440) | 2.50703646 |
| 152 | actin filament capping (GO:0051693) | 2.50320855 |
| 153 | thioester metabolic process (GO:0035383) | 2.48287614 |
| 154 | acyl-CoA metabolic process (GO:0006637) | 2.48287614 |
| 155 | brown fat cell differentiation (GO:0050873) | 2.48060958 |
| 156 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.47643595 |
| 157 | lipid particle organization (GO:0034389) | 2.46045979 |
| 158 | fatty acid beta-oxidation (GO:0006635) | 2.45409299 |
| 159 | fibril organization (GO:0097435) | 2.45294052 |
| 160 | cellular response to epinephrine stimulus (GO:0071872) | 2.44527270 |
| 161 | urea cycle (GO:0000050) | 2.44339010 |
| 162 | adenosine receptor signaling pathway (GO:0001973) | 2.43980227 |
| 163 | negative regulation of macrophage differentiation (GO:0045650) | 2.43411316 |
| 164 | cellular response to cadmium ion (GO:0071276) | 2.42964889 |
| 165 | nitrogen cycle metabolic process (GO:0071941) | 2.42395364 |
| 166 | aromatic amino acid family metabolic process (GO:0009072) | 2.40923059 |
| 167 | regulation of hematopoietic progenitor cell differentiation (GO:1901532) | 2.40647537 |
| 168 | positive regulation of leukocyte mediated immunity (GO:0002705) | 2.39642432 |
| 169 | relaxation of smooth muscle (GO:0044557) | 2.36517261 |
| 170 | lung lobe morphogenesis (GO:0060463) | 2.28357214 |
| 171 | lysosome localization (GO:0032418) | 2.28119848 |
| 172 | positive regulation of macrophage activation (GO:0043032) | 2.28101111 |
| 173 | positive regulation of astrocyte differentiation (GO:0048711) | 2.27613972 |
| 174 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.22966835 |
| 175 | histamine secretion (GO:0001821) | 2.20452594 |
| 176 | response to corticosterone (GO:0051412) | 2.18875195 |
| 177 | leukocyte degranulation (GO:0043299) | 2.18683966 |
| 178 | negative regulation of bone resorption (GO:0045779) | 2.13452039 |
| 179 | negative regulation of complement activation (GO:0045916) | 2.08359269 |
| 180 | mating behavior (GO:0007617) | 2.08076697 |
| 181 | fatty acid derivative metabolic process (GO:1901568) | 2.07500572 |
| 182 | icosanoid metabolic process (GO:0006690) | 2.07500572 |
| 183 | blood coagulation, intrinsic pathway (GO:0007597) | 2.06277930 |
| 184 | fibrinolysis (GO:0042730) | 2.03683848 |
| 185 | muscle organ morphogenesis (GO:0048644) | 2.01501151 |
| 186 | positive regulation of mast cell degranulation (GO:0043306) | 18.3547116 |
| 187 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 18.3547116 |
| 188 | regulation of hypersensitivity (GO:0002883) | 16.6924424 |
| 189 | positive regulation of mast cell activation (GO:0033005) | 15.2648823 |
| 190 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 14.9710675 |
| 191 | positive regulation of leukocyte degranulation (GO:0043302) | 13.7263583 |
| 192 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 11.8551018 |
| 193 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 11.4494254 |
| 194 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 11.3252032 |
| 195 | response to follicle-stimulating hormone (GO:0032354) | 1.98777902 |
| 196 | positive regulation of Rho protein signal transduction (GO:0035025) | 1.98735482 |
| 197 | positive regulation of inflammatory response (GO:0050729) | 1.98458379 |
| 198 | signal peptide processing (GO:0006465) | 1.97474633 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SCL_19346495_ChIP-Seq_HPC-7_Human | 5.08751369 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.88927507 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.82514460 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.72977151 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.68746698 |
| 6 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.59689492 |
| 7 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.58024666 |
| 8 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.50161829 |
| 9 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.42980655 |
| 10 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.31103612 |
| 11 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.30532028 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.20036102 |
| 13 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.19661373 |
| 14 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.11473718 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.08355736 |
| 16 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.06033114 |
| 17 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 2.00113897 |
| 18 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 13.6138410 |
| 19 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.89645013 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.88657442 |
| 21 | GATA1_19941826_ChIP-Seq_K562_Human | 1.82377691 |
| 22 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.82034656 |
| 23 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.81776039 |
| 24 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.81774488 |
| 25 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.80500874 |
| 26 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.78367105 |
| 27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.76744761 |
| 28 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.73596767 |
| 29 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.72333626 |
| 30 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.71961741 |
| 31 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.70735320 |
| 32 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.68737800 |
| 33 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.65357813 |
| 34 | MAF_26560356_Chip-Seq_TH1_Human | 1.63699632 |
| 35 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.63560980 |
| 36 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.63413859 |
| 37 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.63361421 |
| 38 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.62735493 |
| 39 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.58550786 |
| 40 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.56185605 |
| 41 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.56170785 |
| 42 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.51196644 |
| 43 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.50420012 |
| 44 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.47237401 |
| 45 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.45272755 |
| 46 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.43919891 |
| 47 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.42852385 |
| 48 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.42281536 |
| 49 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.41285269 |
| 50 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.40749298 |
| 51 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.39591303 |
| 52 | SPI1_23127762_ChIP-Seq_K562_Human | 1.39510254 |
| 53 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.37373157 |
| 54 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.36024443 |
| 55 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.32696256 |
| 56 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.32299859 |
| 57 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.32002816 |
| 58 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.31293064 |
| 59 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.29310928 |
| 60 | MYC_22102868_ChIP-Seq_BL_Human | 1.27814182 |
| 61 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.27325383 |
| 62 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24816154 |
| 63 | GATA2_19941826_ChIP-Seq_K562_Human | 1.24722791 |
| 64 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.24710375 |
| 65 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.24672266 |
| 66 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24382982 |
| 67 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.23785542 |
| 68 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.23785542 |
| 69 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.23473899 |
| 70 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.23331413 |
| 71 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.21069278 |
| 72 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.20873141 |
| 73 | TP53_16413492_ChIP-PET_HCT116_Human | 1.20347064 |
| 74 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.19982405 |
| 75 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.19973597 |
| 76 | UTX_26944678_Chip-Seq_JUKART_Human | 1.17972405 |
| 77 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17888098 |
| 78 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.16294883 |
| 79 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.14594672 |
| 80 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.14086080 |
| 81 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13761607 |
| 82 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.09876798 |
| 83 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.08836551 |
| 84 | MYB_26560356_Chip-Seq_TH2_Human | 1.08618118 |
| 85 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.08117747 |
| 86 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.07974482 |
| 87 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.07607891 |
| 88 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.05382847 |
| 89 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.05088225 |
| 90 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.05034208 |
| 91 | * EGR1_19032775_ChIP-ChIP_M12_Human | 1.03647592 |
| 92 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.03501744 |
| 93 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03376097 |
| 94 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.03338283 |
| 95 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.02523699 |
| 96 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02018655 |
| 97 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.01289435 |
| 98 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.01259198 |
| 99 | RXR_22108803_ChIP-Seq_LS180_Human | 1.00687692 |
| 100 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.00509881 |
| 101 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.99870557 |
| 102 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.97682777 |
| 103 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.97295171 |
| 104 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.97101961 |
| 105 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.96524342 |
| 106 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.95962114 |
| 107 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.95221270 |
| 108 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.95085463 |
| 109 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.94557240 |
| 110 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.93722544 |
| 111 | KDM2B_26808549_Chip-Seq_K562_Human | 0.93561782 |
| 112 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.93358095 |
| 113 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.93289064 |
| 114 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.93190144 |
| 115 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.92378731 |
| 116 | CJUN_26792858_Chip-Seq_BT549_Human | 0.91864736 |
| 117 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.90871413 |
| 118 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.90793622 |
| 119 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.90243805 |
| 120 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90222402 |
| 121 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.90026008 |
| 122 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.89459420 |
| 123 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.88655153 |
| 124 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.88449116 |
| 125 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.87454387 |
| 126 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.86593865 |
| 127 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.85616247 |
| 128 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.85560723 |
| 129 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.85182486 |
| 130 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.83847219 |
| 131 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.83727638 |
| 132 | * GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.83576451 |
| 133 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.83129978 |
| 134 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83077563 |
| 135 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.82813071 |
| 136 | * BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.82675715 |
| 137 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82550081 |
| 138 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.82173185 |
| 139 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.82084987 |
| 140 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.82084987 |
| 141 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.82084987 |
| 142 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.82082704 |
| 143 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.81658977 |
| 144 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.81260168 |
| 145 | MYB_26560356_Chip-Seq_TH1_Human | 0.79409371 |
| 146 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.79369744 |
| 147 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.79075638 |
| 148 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.78942024 |
| 149 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.78632934 |
| 150 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.78133849 |
| 151 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.78124592 |
| 152 | SA1_27219007_Chip-Seq_Bcells_Human | 0.78092571 |
| 153 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.75686979 |
| 154 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.74795107 |
| 155 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.72097206 |
| 156 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.70504812 |
| 157 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.70423597 |
| 158 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.69104501 |
| 159 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.67135976 |
| 160 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.67086741 |
| 161 | GATA1_22025678_ChIP-Seq_K562_Human | 0.66364201 |
| 162 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.65850310 |
| 163 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.65770434 |
| 164 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.65060711 |
| 165 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.64246678 |
| 166 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.63523705 |
| 167 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.63453800 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002877_abnormal_melanocyte_morpholog | 5.69926352 |
| 2 | MP0005275_abnormal_skin_tensile | 5.36608036 |
| 3 | MP0005670_abnormal_white_adipose | 4.88984119 |
| 4 | MP0000465_gastrointestinal_hemorrhage | 4.80712692 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 3.96755615 |
| 6 | MP0008775_abnormal_heart_ventricle | 3.94253644 |
| 7 | MP0010234_abnormal_vibrissa_follicle | 3.92844194 |
| 8 | MP0002796_impaired_skin_barrier | 3.87229032 |
| 9 | MP0003638_abnormal_response/metabolism_ | 3.52224213 |
| 10 | MP0004808_abnormal_hematopoietic_stem | 3.38988643 |
| 11 | MP0005666_abnormal_adipose_tissue | 3.36963131 |
| 12 | MP0005464_abnormal_platelet_physiology | 3.31198712 |
| 13 | MP0002971_abnormal_brown_adipose | 3.24905255 |
| 14 | MP0003724_increased_susceptibility_to | 3.23788727 |
| 15 | MP0003436_decreased_susceptibility_to | 3.15119599 |
| 16 | MP0003566_abnormal_cell_adhesion | 3.02834249 |
| 17 | MP0009765_abnormal_xenobiotic_induced | 2.83652600 |
| 18 | MP0004130_abnormal_muscle_cell | 2.71701093 |
| 19 | MP0003300_gastrointestinal_ulcer | 2.59653710 |
| 20 | MP0004147_increased_porphyrin_level | 2.55581160 |
| 21 | MP0003011_delayed_dark_adaptation | 2.27716083 |
| 22 | MP0005375_adipose_tissue_phenotype | 2.24760417 |
| 23 | MP0009115_abnormal_fat_cell | 2.22832546 |
| 24 | MP0002419_abnormal_innate_immunity | 2.21803387 |
| 25 | MP0003303_peritoneal_inflammation | 2.17699283 |
| 26 | MP0005501_abnormal_skin_physiology | 2.13883291 |
| 27 | MP0010329_abnormal_lipoprotein_level | 2.11754877 |
| 28 | MP0005503_abnormal_tendon_morphology | 2.10015556 |
| 29 | MP0002398_abnormal_bone_marrow | 2.07612117 |
| 30 | MP0001800_abnormal_humoral_immune | 2.04558706 |
| 31 | MP0005025_abnormal_response_to | 2.03217486 |
| 32 | MP0005409_darkened_coat_color | 1.99817296 |
| 33 | MP0001790_abnormal_immune_system | 1.99716749 |
| 34 | MP0005387_immune_system_phenotype | 1.99716749 |
| 35 | MP0005535_abnormal_body_temperature | 1.98217760 |
| 36 | MP0005000_abnormal_immune_tolerance | 1.93489721 |
| 37 | * MP0002420_abnormal_adaptive_immunity | 1.90292310 |
| 38 | * MP0001819_abnormal_immune_cell | 1.89440677 |
| 39 | MP0000249_abnormal_blood_vessel | 1.87328635 |
| 40 | MP0006082_CNS_inflammation | 1.87175566 |
| 41 | MP0004885_abnormal_endolymph | 1.83806161 |
| 42 | MP0000516_abnormal_urinary_system | 1.82651929 |
| 43 | MP0005367_renal/urinary_system_phenotyp | 1.82651929 |
| 44 | MP0008873_increased_physiological_sensi | 1.81397549 |
| 45 | MP0005646_abnormal_pituitary_gland | 1.78082995 |
| 46 | MP0000751_myopathy | 1.75088175 |
| 47 | MP0003941_abnormal_skin_development | 1.73708449 |
| 48 | MP0002723_abnormal_immune_serum | 1.69157767 |
| 49 | MP0009379_abnormal_foot_pigmentation | 1.64785789 |
| 50 | MP0004381_abnormal_hair_follicle | 1.64611926 |
| 51 | MP0008438_abnormal_cutaneous_collagen | 1.63770312 |
| 52 | MP0002970_abnormal_white_adipose | 1.63168368 |
| 53 | MP0002876_abnormal_thyroid_physiology | 1.61503025 |
| 54 | MP0003453_abnormal_keratinocyte_physiol | 1.61488560 |
| 55 | MP0004858_abnormal_nervous_system | 1.60166013 |
| 56 | MP0005671_abnormal_response_to | 1.59680804 |
| 57 | MP0005174_abnormal_tail_pigmentation | 1.56432314 |
| 58 | MP0001533_abnormal_skeleton_physiology | 1.52539318 |
| 59 | MP0005365_abnormal_bile_salt | 1.50871773 |
| 60 | MP0002909_abnormal_adrenal_gland | 1.49465150 |
| 61 | MP0005167_abnormal_blood-brain_barrier | 1.48837024 |
| 62 | MP0002722_abnormal_immune_system | 1.47994508 |
| 63 | MP0002452_abnormal_antigen_presenting | 1.46659192 |
| 64 | MP0003329_amyloid_beta_deposits | 1.45435101 |
| 65 | MP0001970_abnormal_pain_threshold | 1.40991732 |
| 66 | MP0002118_abnormal_lipid_homeostasis | 1.40900744 |
| 67 | MP0005623_abnormal_meninges_morphology | 1.40658998 |
| 68 | MP0008770_decreased_survivor_rate | 1.38302446 |
| 69 | MP0010307_abnormal_tumor_latency | 1.33648220 |
| 70 | MP0008469_abnormal_protein_level | 1.33104707 |
| 71 | MP0009763_increased_sensitivity_to | 1.32650386 |
| 72 | MP0000716_abnormal_immune_system | 1.31509708 |
| 73 | MP0004924_abnormal_behavior | 1.31013271 |
| 74 | MP0005386_behavior/neurological_phenoty | 1.31013271 |
| 75 | MP0002733_abnormal_thermal_nociception | 1.30915695 |
| 76 | MP0002405_respiratory_system_inflammati | 1.30413559 |
| 77 | MP0001216_abnormal_epidermal_layer | 1.28626862 |
| 78 | MP0003866_abnormal_defecation | 1.28605547 |
| 79 | MP0000343_altered_response_to | 1.27659132 |
| 80 | MP0002429_abnormal_blood_cell | 1.23723473 |
| 81 | MP0010678_abnormal_skin_adnexa | 1.21094409 |
| 82 | MP0003868_abnormal_feces_composition | 1.18786153 |
| 83 | MP0001188_hyperpigmentation | 1.16833951 |
| 84 | MP0009840_abnormal_foam_cell | 1.16417077 |
| 85 | MP0004859_abnormal_synaptic_plasticity | 1.15920926 |
| 86 | MP0000579_abnormal_nail_morphology | 1.15888437 |
| 87 | MP0006138_congestive_heart_failure | 1.13792106 |
| 88 | MP0005075_abnormal_melanosome_morpholog | 1.05410343 |
| 89 | MP0005058_abnormal_lysosome_morphology | 1.05190904 |
| 90 | MP0002933_joint_inflammation | 1.04649676 |
| 91 | MP0002254_reproductive_system_inflammat | 1.04649548 |
| 92 | MP0004043_abnormal_pH_regulation | 1.04632917 |
| 93 | MP0000858_altered_metastatic_potential | 1.04291897 |
| 94 | MP0001845_abnormal_inflammatory_respons | 1.03441090 |
| 95 | MP0004019_abnormal_vitamin_homeostasis | 1.02354798 |
| 96 | MP0000604_amyloidosis | 1.01589609 |
| 97 | MP0002396_abnormal_hematopoietic_system | 1.01059220 |
| 98 | MP0004085_abnormal_heartbeat | 1.00069262 |
| 99 | MP0002098_abnormal_vibrissa_morphology | 0.99972036 |
| 100 | MP0009643_abnormal_urine_homeostasis | 0.99547255 |
| 101 | MP0010771_integument_phenotype | 0.99392228 |
| 102 | MP0004883_abnormal_blood_vessel | 0.99225798 |
| 103 | MP0002166_altered_tumor_susceptibility | 0.97732018 |
| 104 | MP0000703_abnormal_thymus_morphology | 0.97238393 |
| 105 | MP0005448_abnormal_energy_balance | 0.96978989 |
| 106 | MP0009785_altered_susceptibility_to | 0.96152839 |
| 107 | MP0000689_abnormal_spleen_morphology | 0.95740503 |
| 108 | MP0001727_abnormal_embryo_implantation | 0.94722965 |
| 109 | MP0004947_skin_inflammation | 0.94066902 |
| 110 | MP0004510_myositis | 0.92910197 |
| 111 | MP0002139_abnormal_hepatobiliary_system | 0.92247137 |
| 112 | MP0001661_extended_life_span | 0.91940890 |
| 113 | MP0000003_abnormal_adipose_tissue | 0.91737959 |
| 114 | MP0009384_cardiac_valve_regurgitation | 0.91636736 |
| 115 | MP0003183_abnormal_peptide_metabolism | 0.91604567 |
| 116 | MP0003828_pulmonary_edema | 0.91602285 |
| 117 | MP0010368_abnormal_lymphatic_system | 0.90776020 |
| 118 | MP0002108_abnormal_muscle_morphology | 0.90692868 |
| 119 | MP0001879_abnormal_lymphatic_vessel | 0.90672644 |
| 120 | MP0008874_decreased_physiological_sensi | 0.90126096 |
| 121 | MP0003879_abnormal_hair_cell | 0.90077280 |
| 122 | MP0003959_abnormal_lean_body | 0.90034896 |
| 123 | MP0005451_abnormal_body_composition | 0.89603984 |
| 124 | MP0003186_abnormal_redox_activity | 0.89421787 |
| 125 | MP0005390_skeleton_phenotype | 0.88910965 |
| 126 | MP0004782_abnormal_surfactant_physiolog | 0.88784704 |
| 127 | MP0003690_abnormal_glial_cell | 0.88635003 |
| 128 | MP0004215_abnormal_myocardial_fiber | 0.88479259 |
| 129 | MP0008004_abnormal_stomach_pH | 0.87699784 |
| 130 | MP0005360_urolithiasis | 0.86243054 |
| 131 | MP0000609_abnormal_liver_physiology | 0.86114764 |
| 132 | MP0003705_abnormal_hypodermis_morpholog | 0.85416357 |
| 133 | MP0009333_abnormal_splenocyte_physiolog | 0.85068177 |
| 134 | MP0001764_abnormal_homeostasis | 0.84730239 |
| 135 | MP0002060_abnormal_skin_morphology | 0.84366489 |
| 136 | MP0005385_cardiovascular_system_phenoty | 0.84262910 |
| 137 | MP0001544_abnormal_cardiovascular_syste | 0.84262910 |
| 138 | MP0001851_eye_inflammation | 0.84070242 |
| 139 | MP0005166_decreased_susceptibility_to | 0.83427578 |
| 140 | MP0003191_abnormal_cellular_cholesterol | 0.81878648 |
| 141 | MP0000462_abnormal_digestive_system | 0.80768447 |
| 142 | MP0002972_abnormal_cardiac_muscle | 0.79131476 |
| 143 | MP0001666_abnormal_nutrient_absorption | 0.78996784 |
| 144 | MP0009780_abnormal_chondrocyte_physiolo | 0.78742177 |
| 145 | MP0005334_abnormal_fat_pad | 0.76830358 |
| 146 | MP0001501_abnormal_sleep_pattern | 0.75238339 |
| 147 | MP0002128_abnormal_blood_circulation | 0.75147757 |
| 148 | MP0000647_abnormal_sebaceous_gland | 0.74863196 |
| 149 | MP0005452_abnormal_adipose_tissue | 0.74348611 |
| 150 | MP0004185_abnormal_adipocyte_glucose | 0.72705157 |
| 151 | MP0001545_abnormal_hematopoietic_system | 0.72702515 |
| 152 | MP0005397_hematopoietic_system_phenotyp | 0.72702515 |
| 153 | MP0010352_gastrointestinal_tract_polyps | 0.72412140 |
| 154 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.72388434 |
| 155 | MP0002138_abnormal_hepatobiliary_system | 0.72328295 |
| 156 | MP0003172_abnormal_lysosome_physiology | 0.72075908 |
| 157 | MP0000230_abnormal_systemic_arterial | 0.72075027 |
| 158 | MP0002078_abnormal_glucose_homeostasis | 0.71068460 |
| 159 | MP0000377_abnormal_hair_follicle | 0.70127253 |
| 160 | MP0001542_abnormal_bone_strength | 0.67987113 |
| 161 | MP0003656_abnormal_erythrocyte_physiolo | 0.65411359 |
| 162 | MP0003795_abnormal_bone_structure | 0.63309671 |
| 163 | MP0003806_abnormal_nucleotide_metabolis | 0.62517696 |
| 164 | MP0008961_abnormal_basal_metabolism | 0.62109865 |
| 165 | MP0001853_heart_inflammation | 0.60589055 |
| 166 | MP0005164_abnormal_response_to | 0.60220523 |
| 167 | MP0010155_abnormal_intestine_physiology | 0.60005471 |
| 168 | MP0001849_ear_inflammation | 0.58781837 |
| 169 | MP0002572_abnormal_emotion/affect_behav | 0.57859156 |
| 170 | MP0003075_altered_response_to | 0.57671356 |
| 171 | MP0008872_abnormal_physiological_respon | 0.57493596 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased mean platelet volume (HP:0011877) | 9.80374655 |
| 2 | Abnormal platelet volume (HP:0011876) | 9.45160206 |
| 3 | Purpura (HP:0000979) | 9.21308756 |
| 4 | Menorrhagia (HP:0000132) | 8.97723886 |
| 5 | Prolonged bleeding time (HP:0003010) | 8.83270510 |
| 6 | Impaired platelet aggregation (HP:0003540) | 8.07131719 |
| 7 | Abnormal platelet function (HP:0011869) | 8.07131719 |
| 8 | Gingival bleeding (HP:0000225) | 7.65217482 |
| 9 | Increased IgE level (HP:0003212) | 5.90481932 |
| 10 | Systemic lupus erythematosus (HP:0002725) | 5.39276795 |
| 11 | Acanthosis nigricans (HP:0000956) | 5.00699963 |
| 12 | Complement deficiency (HP:0004431) | 4.80463438 |
| 13 | Papilledema (HP:0001085) | 4.60696536 |
| 14 | Epistaxis (HP:0000421) | 4.56629092 |
| 15 | Palmoplantar hyperkeratosis (HP:0000972) | 4.55239887 |
| 16 | Erythema (HP:0010783) | 4.51593658 |
| 17 | Aplastic anemia (HP:0001915) | 4.26770957 |
| 18 | Palmar hyperkeratosis (HP:0010765) | 4.25811813 |
| 19 | Abnormality of complement system (HP:0005339) | 4.21090994 |
| 20 | Oligomenorrhea (HP:0000876) | 3.88549522 |
| 21 | Abnormality of nail color (HP:0100643) | 3.77763867 |
| 22 | Hypertriglyceridemia (HP:0002155) | 3.73410000 |
| 23 | Plantar hyperkeratosis (HP:0007556) | 3.71172910 |
| 24 | Erythroderma (HP:0001019) | 3.66606629 |
| 25 | Glomerulonephritis (HP:0000099) | 3.22750126 |
| 26 | Alopecia of scalp (HP:0002293) | 3.22012596 |
| 27 | Bruising susceptibility (HP:0000978) | 3.20982337 |
| 28 | Cellulitis (HP:0100658) | 3.18946522 |
| 29 | Conjunctival hamartoma (HP:0100780) | 3.12094399 |
| 30 | Esophageal neoplasm (HP:0100751) | 3.10922208 |
| 31 | Neoplasm of head and neck (HP:0012288) | 3.10922208 |
| 32 | Hypotrichosis (HP:0001006) | 3.09348562 |
| 33 | Sex reversal (HP:0012245) | 3.05068324 |
| 34 | Abnormal sex determination (HP:0012244) | 3.05068324 |
| 35 | Woolly hair (HP:0002224) | 2.94649167 |
| 36 | Diplopia (HP:0000651) | 2.93115700 |
| 37 | Abnormality of binocular vision (HP:0011514) | 2.93115700 |
| 38 | Growth hormone excess (HP:0000845) | 2.89448488 |
| 39 | Chronic otitis media (HP:0000389) | 2.82645171 |
| 40 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.82032478 |
| 41 | Bone cyst (HP:0012062) | 2.81274693 |
| 42 | Fragile nails (HP:0001808) | 2.79537353 |
| 43 | White forelock (HP:0002211) | 2.77960811 |
| 44 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.74116673 |
| 45 | Poikilocytosis (HP:0004447) | 2.72214568 |
| 46 | Muscle fiber splitting (HP:0003555) | 2.69865232 |
| 47 | Pili torti (HP:0003777) | 2.68524528 |
| 48 | Malnutrition (HP:0004395) | 2.68078201 |
| 49 | Thick nail (HP:0001805) | 2.62764563 |
| 50 | Recurrent bacterial skin infections (HP:0005406) | 2.61437683 |
| 51 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.60073186 |
| 52 | Hypercortisolism (HP:0001578) | 2.59611818 |
| 53 | Ileus (HP:0002595) | 2.58172001 |
| 54 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.58026969 |
| 55 | Onycholysis (HP:0001806) | 2.57003401 |
| 56 | Abnormality of the axillary hair (HP:0100134) | 2.55815657 |
| 57 | Abnormality of secondary sexual hair (HP:0009888) | 2.55815657 |
| 58 | Insomnia (HP:0100785) | 2.51328772 |
| 59 | Hemorrhage of the eye (HP:0011885) | 2.47201579 |
| 60 | Recurrent viral infections (HP:0004429) | 2.45391680 |
| 61 | Nephritis (HP:0000123) | 2.44819806 |
| 62 | Hypergammaglobulinemia (HP:0010702) | 2.44807461 |
| 63 | Emphysema (HP:0002097) | 2.44748950 |
| 64 | Abnormal hair laboratory examination (HP:0003328) | 2.42804680 |
| 65 | Type 1 muscle fiber predominance (HP:0003803) | 2.42053894 |
| 66 | Difficulty running (HP:0009046) | 2.41540350 |
| 67 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.39347842 |
| 68 | Patchy hypopigmentation of hair (HP:0011365) | 2.37958504 |
| 69 | Cerebral aneurysm (HP:0004944) | 2.37437731 |
| 70 | Supranuclear gaze palsy (HP:0000605) | 2.36260394 |
| 71 | Exercise-induced myalgia (HP:0003738) | 2.32103778 |
| 72 | Neurofibrillary tangles (HP:0002185) | 2.32068446 |
| 73 | Hyperlipoproteinemia (HP:0010980) | 2.31679313 |
| 74 | Recurrent abscess formation (HP:0002722) | 2.28736164 |
| 75 | Cerebral inclusion bodies (HP:0100314) | 2.28385882 |
| 76 | Gastrointestinal stroma tumor (HP:0100723) | 2.27487817 |
| 77 | Increased connective tissue (HP:0009025) | 2.26247505 |
| 78 | Right ventricular cardiomyopathy (HP:0011663) | 2.24655179 |
| 79 | Follicular hyperkeratosis (HP:0007502) | 2.24207090 |
| 80 | Polyphagia (HP:0002591) | 2.23868310 |
| 81 | Fat malabsorption (HP:0002630) | 2.23241968 |
| 82 | Insulin resistance (HP:0000855) | 2.21839855 |
| 83 | Rhabdomyolysis (HP:0003201) | 2.21760329 |
| 84 | Increased variability in muscle fiber diameter (HP:0003557) | 2.21151307 |
| 85 | Nausea (HP:0002018) | 2.19347250 |
| 86 | Myoglobinuria (HP:0002913) | 2.18938124 |
| 87 | Eczematoid dermatitis (HP:0000976) | 2.17149712 |
| 88 | Heterochromia iridis (HP:0001100) | 2.13082946 |
| 89 | Slender build (HP:0001533) | 2.11401594 |
| 90 | Epidermoid cyst (HP:0200040) | 2.07789501 |
| 91 | Axonal loss (HP:0003447) | 2.07377905 |
| 92 | Palmoplantar keratoderma (HP:0000982) | 2.07084352 |
| 93 | Long foot (HP:0001833) | 2.01803375 |
| 94 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.01008486 |
| 95 | Hyperacusis (HP:0010780) | 2.00655897 |
| 96 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.00460621 |
| 97 | Increased muscle lipid content (HP:0009058) | 2.00026041 |
| 98 | Petechiae (HP:0000967) | 12.1401734 |
| 99 | Steatorrhea (HP:0002570) | 1.99832608 |
| 100 | Gangrene (HP:0100758) | 1.99470050 |
| 101 | Abnormality of oral frenula (HP:0000190) | 1.99315223 |
| 102 | Hematochezia (HP:0002573) | 1.96311918 |
| 103 | Acute myeloid leukemia (HP:0004808) | 1.95638164 |
| 104 | Vertebral compression fractures (HP:0002953) | 1.94823246 |
| 105 | Hyporeflexia of lower limbs (HP:0002600) | 1.94290043 |
| 106 | Germ cell neoplasia (HP:0100728) | 1.94150422 |
| 107 | Urticaria (HP:0001025) | 1.92488685 |
| 108 | Apathy (HP:0000741) | 1.90185916 |
| 109 | Amyloidosis (HP:0011034) | 1.89710306 |
| 110 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.89389540 |
| 111 | Pigmentary retinal degeneration (HP:0001146) | 1.88863043 |
| 112 | Protrusio acetabuli (HP:0003179) | 1.88817041 |
| 113 | Hydroxyprolinuria (HP:0003080) | 1.88505152 |
| 114 | Abnormality of proline metabolism (HP:0010907) | 1.88505152 |
| 115 | Tetraparesis (HP:0002273) | 1.85047502 |
| 116 | Hyperparathyroidism (HP:0000843) | 1.82623551 |
| 117 | Mucopolysacchariduria (HP:0008155) | 1.82404643 |
| 118 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.82404643 |
| 119 | Metaphyseal dysplasia (HP:0100255) | 1.81063390 |
| 120 | Widely patent fontanelles and sutures (HP:0004492) | 1.80967563 |
| 121 | Multiple lipomas (HP:0001012) | 1.80626873 |
| 122 | Deep venous thrombosis (HP:0002625) | 1.80548263 |
| 123 | Recurrent fungal infections (HP:0002841) | 1.78799387 |
| 124 | Abnormal eating behavior (HP:0100738) | 1.78396450 |
| 125 | Neonatal onset (HP:0003623) | 1.77995259 |
| 126 | Absent eyelashes (HP:0000561) | 1.77759195 |
| 127 | Ulnar claw (HP:0001178) | 1.76789955 |
| 128 | Hamartoma of the eye (HP:0010568) | 1.76598236 |
| 129 | Thin bony cortex (HP:0002753) | 1.76552913 |
| 130 | Skin nodule (HP:0200036) | 1.76137536 |
| 131 | IgM deficiency (HP:0002850) | 1.75078215 |
| 132 | Diminished motivation (HP:0000745) | 1.74039967 |
| 133 | Villous atrophy (HP:0011473) | 1.72585428 |
| 134 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.72585428 |
| 135 | Distal lower limb muscle weakness (HP:0009053) | 1.72366623 |
| 136 | Ridged nail (HP:0001807) | 1.72088614 |
| 137 | Hypoalphalipoproteinemia (HP:0003233) | 1.71797702 |
| 138 | Prominent supraorbital ridges (HP:0000336) | 1.71498643 |
| 139 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.71230008 |
| 140 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.70293694 |
| 141 | Calf muscle hypertrophy (HP:0008981) | 1.69343181 |
| 142 | Disproportionate tall stature (HP:0001519) | 1.63628988 |
| 143 | Renal salt wasting (HP:0000127) | 1.61562357 |
| 144 | Spontaneous hematomas (HP:0007420) | 1.60024456 |
| 145 | Leukocytosis (HP:0001974) | 1.59500688 |
| 146 | Xanthomatosis (HP:0000991) | 1.56307359 |
| 147 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.55541194 |
| 148 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.55541194 |
| 149 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.55541194 |
| 150 | Increased density of long bones (HP:0006392) | 1.54504324 |
| 151 | Inflammation of the large intestine (HP:0002037) | 1.53297519 |
| 152 | Hemiplegia (HP:0002301) | 1.53101677 |
| 153 | Polycythemia (HP:0001901) | 1.51482503 |
| 154 | Gonadal dysgenesis (HP:0000133) | 1.50702860 |
| 155 | Joint hemorrhage (HP:0005261) | 1.49103160 |
| 156 | Neoplasm of the rectum (HP:0100743) | 1.48915384 |
| 157 | Large hands (HP:0001176) | 1.48239720 |
| 158 | Ankyloglossia (HP:0010296) | 1.48212798 |
| 159 | Hyperaldosteronism (HP:0000859) | 1.47303684 |
| 160 | Shallow orbits (HP:0000586) | 1.46893180 |
| 161 | Global brain atrophy (HP:0002283) | 1.46885870 |
| 162 | Fibroma (HP:0010614) | 1.46709785 |
| 163 | Abnormality of the Achilles tendon (HP:0005109) | 1.46301612 |
| 164 | Gastrointestinal inflammation (HP:0004386) | 1.45606005 |
| 165 | Striae distensae (HP:0001065) | 1.44563198 |
| 166 | Nasal polyposis (HP:0100582) | 1.43008945 |
| 167 | Achilles tendon contracture (HP:0001771) | 1.41915716 |
| 168 | Aortic aneurysm (HP:0004942) | 1.41853893 |
| 169 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.40285960 |
| 170 | Fibrous tissue neoplasm (HP:0012316) | 1.40066251 |
| 171 | Increased cerebral lipofuscin (HP:0011813) | 1.39234868 |
| 172 | Recurrent skin infections (HP:0001581) | 1.37462939 |
| 173 | Severe short stature (HP:0003510) | 1.36630548 |
| 174 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.36046098 |
| 175 | Acrocyanosis (HP:0001063) | 1.34288763 |
| 176 | Cervical subluxation (HP:0003308) | 1.34131980 |
| 177 | Colitis (HP:0002583) | 1.33577182 |
| 178 | Abnormality of eosinophils (HP:0001879) | 1.32619456 |
| 179 | Arterial tortuosity (HP:0005116) | 1.31570829 |
| 180 | Abnormality of the lower motor neuron (HP:0002366) | 1.31265565 |
| 181 | Adrenal overactivity (HP:0002717) | 1.31050099 |
| 182 | Sudden cardiac death (HP:0001645) | 1.29964903 |
| 183 | Neoplasm of the small intestine (HP:0100833) | 1.28668975 |
| 184 | Overriding aorta (HP:0002623) | 1.27671182 |
| 185 | Thoracolumbar scoliosis (HP:0002944) | 1.26088227 |
| 186 | Lymphedema (HP:0001004) | 1.25936202 |
| 187 | Myocardial infarction (HP:0001658) | 1.25076575 |
| 188 | Abnormality of the prostate (HP:0008775) | 1.24485870 |
| 189 | Bronchomalacia (HP:0002780) | 1.23534260 |
| 190 | Mitral stenosis (HP:0001718) | 1.23476329 |
| 191 | Abnormality of the nasal mucosa (HP:0000433) | 1.22551449 |
| 192 | Hand muscle atrophy (HP:0009130) | 1.21777661 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KIT | 6.94576565 |
| 2 | MATK | 4.36651141 |
| 3 | PDK2 | 3.87194700 |
| 4 | EEF2K | 3.71548673 |
| 5 | RIPK4 | 3.50328588 |
| 6 | FES | 3.17473678 |
| 7 | MAP4K1 | 3.07699915 |
| 8 | EPHB2 | 2.87981567 |
| 9 | TXK | 2.54784331 |
| 10 | DDR2 | 2.53160807 |
| 11 | CDK6 | 2.49378922 |
| 12 | TRIB3 | 2.48057638 |
| 13 | NTRK2 | 2.33710346 |
| 14 | MYLK | 1.96503934 |
| 15 | MAPKAPK5 | 1.80622580 |
| 16 | GRK6 | 1.78228904 |
| 17 | FGFR2 | 1.74482267 |
| 18 | EPHA3 | 1.72439342 |
| 19 | TYK2 | 1.71167341 |
| 20 | TGFBR2 | 1.68666292 |
| 21 | MAPKAPK3 | 1.66770495 |
| 22 | PIM2 | 1.65862507 |
| 23 | ZAP70 | 1.65512191 |
| 24 | SYK | 1.62007473 |
| 25 | ERBB3 | 1.52170148 |
| 26 | STK38L | 1.48628088 |
| 27 | MAPK12 | 1.47749497 |
| 28 | MAPK15 | 1.44926064 |
| 29 | SIK2 | 1.42672000 |
| 30 | FGFR4 | 1.41366189 |
| 31 | ITK | 1.40767622 |
| 32 | PKN2 | 1.38533095 |
| 33 | MARK1 | 1.37193510 |
| 34 | FER | 1.33759882 |
| 35 | CSNK1G3 | 1.33332596 |
| 36 | OBSCN | 1.32117977 |
| 37 | PTK6 | 1.29239857 |
| 38 | TIE1 | 1.26593276 |
| 39 | PRKAA2 | 1.26589344 |
| 40 | JAK2 | 1.26389830 |
| 41 | MAPKAPK2 | 1.26097876 |
| 42 | TESK1 | 1.25602290 |
| 43 | BMX | 1.25405980 |
| 44 | NEK9 | 1.23372021 |
| 45 | TGFBR1 | 1.20853279 |
| 46 | LATS1 | 1.19659320 |
| 47 | PRKACG | 1.19260638 |
| 48 | LYN | 1.16307585 |
| 49 | PIK3CA | 1.14222605 |
| 50 | CAMK1G | 1.14133775 |
| 51 | TYRO3 | 1.11691194 |
| 52 | PRPF4B | 1.09586696 |
| 53 | SIK1 | 1.07719462 |
| 54 | TAOK1 | 1.07126832 |
| 55 | TAOK3 | 1.06395287 |
| 56 | MAPK7 | 1.05276627 |
| 57 | LRRK2 | 1.04152596 |
| 58 | TRPM7 | 1.02127055 |
| 59 | CSNK1G2 | 1.02061393 |
| 60 | BLK | 1.00147082 |
| 61 | CAMK1D | 1.00144987 |
| 62 | MAP3K5 | 0.99131382 |
| 63 | ABL2 | 0.96792614 |
| 64 | ALK | 0.96707708 |
| 65 | RPS6KB2 | 0.94487016 |
| 66 | PRKACB | 0.91567103 |
| 67 | PDPK1 | 0.90088154 |
| 68 | CAMKK2 | 0.89393744 |
| 69 | STK24 | 0.89234030 |
| 70 | ARAF | 0.88746715 |
| 71 | MARK2 | 0.88558651 |
| 72 | GRK5 | 0.88419205 |
| 73 | CDC42BPA | 0.88386253 |
| 74 | HIPK2 | 0.88042855 |
| 75 | ACVR1B | 0.84747243 |
| 76 | STK10 | 0.83852709 |
| 77 | MAP2K4 | 0.80430657 |
| 78 | SCYL2 | 0.80124041 |
| 79 | CAMKK1 | 0.79731112 |
| 80 | CSNK1G1 | 0.79668289 |
| 81 | BTK | 0.75506306 |
| 82 | FGFR3 | 0.70603491 |
| 83 | PDGFRA | 0.70510392 |
| 84 | NME1 | 0.67166150 |
| 85 | CSF1R | 0.67052317 |
| 86 | HCK | 0.66371557 |
| 87 | MAPK13 | 0.66142199 |
| 88 | PKN1 | 0.66120374 |
| 89 | PHKG1 | 0.64846037 |
| 90 | PHKG2 | 0.64846037 |
| 91 | BCR | 0.64764457 |
| 92 | LMTK2 | 0.64605859 |
| 93 | PRKD2 | 0.63375555 |
| 94 | PAK2 | 0.62690884 |
| 95 | TEC | 0.61002873 |
| 96 | RPS6KA2 | 0.60859687 |
| 97 | JAK1 | 0.60165784 |
| 98 | MAP2K1 | 0.59413631 |
| 99 | IKBKE | 0.59210504 |
| 100 | NME2 | 0.58094428 |
| 101 | LCK | 0.58037440 |
| 102 | MAP3K7 | 0.56380443 |
| 103 | STK38 | 0.55966062 |
| 104 | PDK1 | 0.54983470 |
| 105 | PRKCQ | 0.54857318 |
| 106 | PIM1 | 0.54830562 |
| 107 | PIK3CG | 0.54786284 |
| 108 | CDK9 | 0.53707668 |
| 109 | DMPK | 0.52839750 |
| 110 | MST1R | 0.52828432 |
| 111 | UHMK1 | 0.51722719 |
| 112 | MAP3K1 | 0.51400883 |
| 113 | SRC | 0.50318065 |
| 114 | MAP3K11 | 0.50181523 |
| 115 | RET | 0.49289629 |
| 116 | EPHB1 | 0.48497430 |
| 117 | ADRBK1 | 0.46830872 |
| 118 | PDGFRB | 0.46209760 |
| 119 | MET | 0.46010216 |
| 120 | DYRK1B | 0.45334638 |
| 121 | MAP2K6 | 0.44601418 |
| 122 | PRKG1 | 0.43909871 |
| 123 | CAMK1 | 0.42189360 |
| 124 | PRKD1 | 0.41758465 |
| 125 | FYN | 0.41652190 |
| 126 | TTN | 0.41574521 |
| 127 | CAMK2G | 0.40749394 |
| 128 | FGR | 0.40545309 |
| 129 | PRKG2 | 0.39919547 |
| 130 | YES1 | 0.39846892 |
| 131 | CAMK4 | 0.39697070 |
| 132 | MAPK11 | 0.38776439 |
| 133 | CDK4 | 0.38559243 |
| 134 | IKBKB | 0.38446706 |
| 135 | PRKAA1 | 0.38140934 |
| 136 | STK39 | 0.37613437 |
| 137 | RIPK1 | 0.37482318 |
| 138 | PRKCB | 0.37341370 |
| 139 | MAP2K7 | 0.37198956 |
| 140 | RPS6KA3 | 0.35245892 |
| 141 | JAK3 | 0.34588863 |
| 142 | MAP3K10 | 0.33709473 |
| 143 | MAP3K2 | 0.32979741 |
| 144 | KSR2 | 0.32760258 |
| 145 | TNK2 | 0.31732082 |
| 146 | DAPK3 | 0.31646356 |
| 147 | TBK1 | 0.31104637 |
| 148 | MAPK4 | 0.28548507 |
| 149 | PRKACA | 0.28544786 |
| 150 | ERN1 | 0.28514604 |
| 151 | PTK2 | 0.25475782 |
| 152 | MAP2K2 | 0.25077104 |
| 153 | CSK | 0.25026341 |
| 154 | MARK3 | 0.24270365 |
| 155 | ILK | 0.24095442 |
| 156 | CDK5 | 0.23410860 |
| 157 | MAP3K6 | 0.23303746 |
| 158 | CAMK2A | 0.22786427 |
| 159 | MAPK1 | 0.22334969 |
| 160 | TESK2 | 0.21921983 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Renin-angiotensin system_Homo sapiens_hsa04614 | 5.97301370 |
| 2 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 3.64291694 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.36232065 |
| 4 | PPAR signaling pathway_Homo sapiens_hsa03320 | 3.15177678 |
| 5 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.78063063 |
| 6 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.74171178 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.45557194 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.42930816 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.19477150 |
| 10 | Asthma_Homo sapiens_hsa05310 | 11.7670142 |
| 11 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.97049626 |
| 12 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.89388285 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.73394629 |
| 14 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.71570063 |
| 15 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.69164650 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.68551004 |
| 17 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.64012487 |
| 18 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.62248863 |
| 19 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.60488433 |
| 20 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.58019434 |
| 21 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.56054460 |
| 22 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.52953936 |
| 23 | Platelet activation_Homo sapiens_hsa04611 | 1.50686696 |
| 24 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.44291022 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.42599032 |
| 26 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.42350142 |
| 27 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.38627717 |
| 28 | Pertussis_Homo sapiens_hsa05133 | 1.35133555 |
| 29 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.27407216 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.26644564 |
| 31 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.26254773 |
| 32 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.25869213 |
| 33 | Cocaine addiction_Homo sapiens_hsa05030 | 1.22618063 |
| 34 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.20987146 |
| 35 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.19603108 |
| 36 | Allograft rejection_Homo sapiens_hsa05330 | 1.09227222 |
| 37 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.07636020 |
| 38 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.06271312 |
| 39 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.06057357 |
| 40 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.05223163 |
| 41 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.02101725 |
| 42 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.98487879 |
| 43 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.95379397 |
| 44 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.94453026 |
| 45 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92389338 |
| 46 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.92202025 |
| 47 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.91164187 |
| 48 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.90624061 |
| 49 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.88977175 |
| 50 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.88027786 |
| 51 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.86891450 |
| 52 | Malaria_Homo sapiens_hsa05144 | 0.86050557 |
| 53 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.84433862 |
| 54 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.83606738 |
| 55 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.83046576 |
| 56 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.76164906 |
| 57 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.73616395 |
| 58 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.73244471 |
| 59 | Prion diseases_Homo sapiens_hsa05020 | 0.71620420 |
| 60 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.70425260 |
| 61 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.70413147 |
| 62 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.69763851 |
| 63 | Mineral absorption_Homo sapiens_hsa04978 | 0.69683233 |
| 64 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.69614922 |
| 65 | Other glycan degradation_Homo sapiens_hsa00511 | 0.69058555 |
| 66 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.68667131 |
| 67 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68534500 |
| 68 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.66353624 |
| 69 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.65747425 |
| 70 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.64026136 |
| 71 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.60511549 |
| 72 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.60218447 |
| 73 | Peroxisome_Homo sapiens_hsa04146 | 0.57905191 |
| 74 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.57742860 |
| 75 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.56869711 |
| 76 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.53303196 |
| 77 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.52200340 |
| 78 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.51769946 |
| 79 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51613134 |
| 80 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.50628696 |
| 81 | ABC transporters_Homo sapiens_hsa02010 | 0.49585318 |
| 82 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.48614858 |
| 83 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.48285441 |
| 84 | Phagosome_Homo sapiens_hsa04145 | 0.47724342 |
| 85 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.47289161 |
| 86 | Long-term potentiation_Homo sapiens_hsa04720 | 0.47034313 |
| 87 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.46242506 |
| 88 | Glioma_Homo sapiens_hsa05214 | 0.45995653 |
| 89 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.45635678 |
| 90 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.45609063 |
| 91 | Tuberculosis_Homo sapiens_hsa05152 | 0.45450529 |
| 92 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.43738401 |
| 93 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.43607207 |
| 94 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.42503946 |
| 95 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.42437148 |
| 96 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.42227048 |
| 97 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.41181272 |
| 98 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.39876834 |
| 99 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.39224199 |
| 100 | Hepatitis C_Homo sapiens_hsa05160 | 0.39041418 |
| 101 | Hepatitis B_Homo sapiens_hsa05161 | 0.38404133 |
| 102 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.38295248 |
| 103 | Leishmaniasis_Homo sapiens_hsa05140 | 0.37487743 |
| 104 | Focal adhesion_Homo sapiens_hsa04510 | 0.36840678 |
| 105 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.36356096 |
| 106 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.34539993 |
| 107 | Histidine metabolism_Homo sapiens_hsa00340 | 0.34459940 |
| 108 | Viral myocarditis_Homo sapiens_hsa05416 | 0.33932270 |
| 109 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.32994399 |
| 110 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.32527976 |
| 111 | Apoptosis_Homo sapiens_hsa04210 | 0.32408727 |
| 112 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.32169934 |
| 113 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.32134997 |
| 114 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.31815410 |
| 115 | Salmonella infection_Homo sapiens_hsa05132 | 0.31649120 |
| 116 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.31501354 |
| 117 | Amoebiasis_Homo sapiens_hsa05146 | 0.31319500 |
| 118 | Colorectal cancer_Homo sapiens_hsa05210 | 0.29300017 |
| 119 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.29211496 |
| 120 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.28842804 |
| 121 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.28729077 |
| 122 | Lysosome_Homo sapiens_hsa04142 | 0.28236082 |
| 123 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.27708703 |
| 124 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.27334220 |
| 125 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.26596878 |
| 126 | Carbon metabolism_Homo sapiens_hsa01200 | 0.26169276 |
| 127 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.26153042 |
| 128 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.25962476 |
| 129 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.25348444 |
| 130 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.24795379 |
| 131 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.24755653 |
| 132 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.24737233 |
| 133 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.23961589 |
| 134 | Gap junction_Homo sapiens_hsa04540 | 0.23951009 |
| 135 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.23943604 |
| 136 | Circadian entrainment_Homo sapiens_hsa04713 | 0.23887803 |
| 137 | Bile secretion_Homo sapiens_hsa04976 | 0.23865714 |
| 138 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.23819402 |
| 139 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.23739236 |
| 140 | Renin secretion_Homo sapiens_hsa04924 | 0.23043576 |
| 141 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.22939971 |
| 142 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.22724613 |
| 143 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.22355528 |
| 144 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.22262204 |
| 145 | Insulin resistance_Homo sapiens_hsa04931 | 0.21857615 |
| 146 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.21716989 |
| 147 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.21354707 |
| 148 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.21121026 |
| 149 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.20670498 |
| 150 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.20221518 |
| 151 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.20119989 |
| 152 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.19723012 |
| 153 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.19405825 |
| 154 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.19126304 |
| 155 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.18987513 |
| 156 | Olfactory transduction_Homo sapiens_hsa04740 | 0.18762883 |
| 157 | Endocytosis_Homo sapiens_hsa04144 | 0.18218401 |
| 158 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.18151923 |
| 159 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.18068595 |
| 160 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.17926603 |
| 161 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.16958835 |
| 162 | Pathways in cancer_Homo sapiens_hsa05200 | 0.16815533 |
| 163 | Morphine addiction_Homo sapiens_hsa05032 | 0.16638198 |
| 164 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.15265928 |

